Press release
Pneumococcal Vaccines Market, 2017-2021 - Industry Applications,Market Share, Segmentation, Company Share: QY Research Reports
qyresearchreports.us
Latest on Pneumococcal Vaccines
Pneumococcal vaccines are manufactured to fight against the bacteria Streptococcus pneumonia bacteria. They are also used in few cases of meningitis, pneumonia, and sepsis. The 2 types of vaccines available in the market are polysaccharide vaccines and conjugate vaccines. The vaccines are given intramuscular or subcutaneous. WHO has recommended using conjugated vaccine in routine immunization of children including those suffering from HIV/AIDS.
In the 1980s, the first pneumococcal vaccine was developed and they are on WHO’s essential medicines list since then. The vaccines works well but cannot prevent 100% of cases. Research has shown that 1 dose of conjugated pneumococcal vaccine protects at least 80% of babies from pneumococcal disease, at least 75 % of adults above 65 years of age from pneumococcal disease, 45% of adults above 65 years of age from pneumococcal pneumonia. 1 dose of pneumococcal polysaccharide vaccine protects 50 to 85% OF healthy adults from pneumococcal disease. The polysaccharide vaccine is given in a single dose with one or two booster doses if required. Conjugate vaccine is given to babies in 3 doses at 2 month, 12 month and 15 months.
Have Any Query? Ask Our Expert: http://www.qyresearchreports.us/send-an-enquiry/global-pneumococcal-vaccines-sales-market-report-2021
Research
Pneumococcal bacteria have many serotypes which are geographically scattered throughout the world. Hence more R&D is required to find out the most effective vaccines, especially in developing countries. Research is being done, to develop a vaccine which can be administered through nose instead of skin or muscles. Also, antibodies which are serotype-specific, anticapsular and monoclonal are being studied recently and they have shown prolonged survival rates, decrease in inflammatory response and reduction of bacterial loads in mouse. Bill and Melinda Gates foundation and 5 countries across the world have invested 1.5 billion US dollars for research on the disease and reduce child mortality because of the same.
Possible side effects of the vaccines includes redness, pain, swelling, myalgia, fever, headache, loss of appetite, irritability etc.
Get Discount on this Report @ http://www.qyresearchreports.us/check-discount/global-pneumococcal-vaccines-sales-market-report-2021
This report studies sales (consumption) of Pneumococcal Vaccines in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
• GlaxoSmithKline
• Sanofi Pasteur
• Merck
• Novartis
• Pfizer
• bioCSL (Seqirus)
• Protein Sciences
Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Pneumococcal Vaccines in these regions, from 2011 to 2021 (forecast), like
• North America
• China
• Europe
• Japan
• Southeast Asia
• India
READ MORE: http://www.qyresearchreports.us/market-analysis/global-pneumococcal-vaccines-sales-market-report-2021
QY Research is your exclusive destination for the entire spectrum of Market Research and Business Solutions. Depending upon the clients, we provide customized as well as syndicated reports. Our market intelligence covers industries like technology, food and beverages, chemical materials, pharmaceuticals and healthcare, agriculture, consumer goods, among others.
Contact Us:
11323 136th Ave East
Puyallup, Wa 98374
United States
Email – Sales@Qyresearchreports.Us
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pneumococcal Vaccines Market, 2017-2021 - Industry Applications,Market Share, Segmentation, Company Share: QY Research Reports here
News-ID: 506805 • Views: …
More Releases from qyresearchreports.us
SUV Ignition Coil Market Supply & Demand Research Report 2017
QY Research Reports analysts estimate the SUV Ignition Coil Market to grow at a substantial CAGR during the forecast period 2017 to 2022.
In this report, the global SUV Ignition Coil market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report split global into several key Regions,…
Fistula Needles Market to See Strong Application Scope Globally from 2017 to 202 …
QY Research Reports analysts estimate the Fistula Needles Market to grow at a substantial CAGR during the forecast period 2017 to 2022.
This report studies Fistula Needles in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.
Get Sample Copy of this Report: https://www.qyresearchreports.us/request-sample/global-fistula-needles-market-professional-survey-report-2017-d-1963
This report focuses on top manufacturers…
Pen Needles Market Report for Period 2017 till 2022
QY Research Reports analysts estimate the Pen Needles Market to grow at a substantial CAGR during the forecast period 2017 to 2022.
This report studies Pen Needles in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.
Get Sample Copy of this Report: https://www.qyresearchreports.us/request-sample/global-pen-needles-market-professional-survey-report-2017-d-1961
This report focuses on top manufacturers…
Biopsy Needles Market Demand Growth Analysis 2017 To 2022
QY Research Reports analysts estimate the Biopsy Needles Market to grow at a substantial CAGR during the forecast period 2017 to 2022.
This report studies Biopsy Needles in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.
Get Sample Copy of this Report: https://www.qyresearchreports.us/request-sample/global-biopsy-needles-market-professional-survey-report-2017-d-1959
This report focuses on top manufacturers…
More Releases for Pneumococcal
Invasive Pneumococcal Disease Market Massive Growth opportunity Ahead
Introduction
Invasive pneumococcal disease (IPD), caused by Streptococcus pneumoniae, remains one of the leading causes of serious illness and death worldwide. Manifesting as meningitis, bacteremia, and severe pneumonia, IPD poses the greatest risk to infants, elderly adults, and immunocompromised patients. Despite progress in immunization, the disease continues to cause a significant global burden, particularly in regions with limited vaccine access.
The Invasive Pneumococcal Disease Market is entering a transformative phase, fueled by…
Key Influencer in the Pneumococcal Vaccine Market 2025: Rising Prevalence Of Pne …
What combination of drivers is leading to accelerated growth in the pneumococcal vaccine market?
The escalating occurrence of pneumococcal infections is projected to boost the pneumococcal vaccine market's growth. Pneumococcal infections represent any condition triggered by the bacterium Streptococcus pneumoniae, also known as pneumococcus. This includes illnesses like pneumonia, bloodstream infections, ear infections, and sinus infections. The pneumococcal vaccine encourages the body to generate antibodies against these bacteria, thereby minimizing or…
Pneumococcal Vaccines Market - Preventing Pneumonia: Safeguarding Health with Pn …
Newark, New Castle, USA: The "Pneumococcal Vaccines Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Pneumococcal Vaccines Market: https://www.growthplusreports.com/report/pneumococcal-vaccines-market/7761
This latest report researches the industry structure, sales, revenue,…
Global To Invigorate The Intravenous Pneumococcal Vaccines Market
Pneumococcal vaccine is used to prevent infection caused by streptococcus pneumoniae bacteria. There are two types of pneumococcal vaccines: pneumococcal conjugate vaccine and pneumococcal polysaccharide vaccine.
The Centers for Disease Control and Prevention (CDC) recommends pneumococcal conjugate vaccine for all children younger than two years of age, all adults 65 years or older, and for people 2-64 years old with certain medical conditions. The CDC recommends pneumococcal polysaccharide vaccine for all…
Pneumococcal Vaccines Market Demands and Gross Margin 2027
"Industry analysis is a crucial step in the current competitive market space that helps identify the right target customers and accordingly provide tailored solutions for their business needs. Every aspect and unique challenges put up by the particular industry are carefully taken into consideration while formulating these solutions. It also takes into consideration various government reforms, competitive environment, customer behavior, existing and upcoming business models, and ever-evolving technological developments. Industry…
Pneumococcal Vaccine Report on Global Pneumococcal Vaccine Market Development, p …
Latest Survey on Pneumococcal Vaccine Market:
The Global Pneumococcal Vaccine market report value has been estimated considering the application and regional segments, market share, and size, while the forecast for each product type and application segment has been provided for the global markets. The Pneumococcal Vaccine report offers detailed profiles of the key players to bring out a clear view of the competitive landscape of the Pneumococcal Vaccine Outlook. It also…
